Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666187 | SCV000790437 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2017-03-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666187 | SCV002181895 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2021-10-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 551197). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val105Profs*104) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). |
Genome- |
RCV000666187 | SCV003931656 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000666187 | SCV005056688 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2024-03-12 | criteria provided, single submitter | clinical testing |